Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Drug companies seek approval to deliver new drug through pre-filled syringes


Progenics Pharmaceuticals Inc. and Wyeth Pharmaceuticals said they have submitted an application to the U.S. Food and Drug Administration and European regulators to approve the use of pre-filled syringes with their Relistor constipation drug. The medication itself has already received regulatory approval.

Progenics, an Eastview-based biotech company, partnered with Wyeth in 2005 to jointly develop and sell Relistor, an injectable drug designed to treat constipation caused by painkillers. If regulators approves the use of the pre-filled syringes, the drug could be available in that form in the United States and Europe by the first half of next year and be easier to administer to patients, according to the companies.

This entry was posted on Tuesday, August 4th, 2009 at 12:48 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical



About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.


Get blog updates via email:

About the Authors


Other recent entries


Monthly Archives